In March 2025, the company introduced new options for a immediate-to-consumer giving of its Wegovy weight loss drug. The company set up a fresh pharmacy, termed NovoCare, which might demand consumers $499 each month for usage of the drug, lower than fifty percent the cost of the drug via other pharmaceutical distribution networks.[fifty three]Novo